Author

Junji Kishimoto

Kyushu university - Cited by 6,104 - medical statistics

Biography

n device-aided therapy (DAT) for Parkinson's disease (PD), factors such as device-related adverse effects, psychological and lifestyle changes, and specific disease progression can affect the quality of life (QoL) of patients with advanced PD. However, there is no existing QoL scale that includes the effects of therapeutic devices.
Title
Cited by
Year
Phase 3 trial comparing nanoparticle albumin-bound paclitaxel with docetaxel for previously treated advanced NSCLC
Y Yoneshima, S Morita, M Ando, A Nakamura, S Iwasawa, H Yoshioka, ...Journal of Thoracic Oncology 16 (9), 1523-1532, 2021202
39
2021
Trastuzumab emtansine for patients with non–small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations
E Iwama, Y Zenke, S Sugawara, H Daga, M Morise, N Yanagitani, ...European Journal of Cancer 162, 99-106, 2022202
25
2022
Osimertinib versus osimertinib plus chemotherapy for non–small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label …
K Tanaka, H Asahina, J Kishimoto, Y Miyata, T Uchida, K Watanabe, ...European Journal of Cancer 149, 14-22, 2021202
23
2021
Assessment of pediatric admissions for Kawasaki disease or infectious disease during the COVID-19 state of emergency in Japan
T Hara, K Furuno, K Yamamura, J Kishimoto, Y Mizuno, K Murata, ...JAMA network open 4 (4), e214475-e214475, 2021202
22
2021
Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial
K Otsubo, J Kishimoto, M Ando, H Kenmotsu, Y Minegishi, H Horinouchi, ...European Respiratory Journal 60 (6), 2022202
15
2022
Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study
K Hotta, S Saeki, M Yamaguchi, D Harada, A Bessho, K Tanaka, K Inoue, ...ESMO open 6 (4), 100191, 2021202
13
2021
Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator …
K Kimura, T Kanto, S Shimoda, K Harada, M Kimura, K Nishikawa, ...EBioMedicine 80, 2022202
11
2022
Machine learning‐based model for predicting 1 year mortality of hospitalized patients with heart failure
T Tohyama, T Ide, M Ikeda, H Kaku, N Enzan, S Matsushima, K Funakoshi, ...ESC Heart Failure 8 (5), 4077-4085, 2021202
11
2021
An open-label phase I/IIa clinical trial of 11β-HSD1 inhibitor for cushing’s syndrome and autonomous cortisol secretion
S Oda, K Ashida, M Uchiyama, S Sakamoto, N Hasuzawa, A Nagayama, ...The Journal of Clinical Endocrinology & Metabolism 6 (), e3865-e3880, 2021202
10
2021
Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studies
N Uchida, K Matsumoto, T Sakura, M Hidaka, T Miyamoto, T Eto, Y Maeda, ...International Journal of Hematology 112, 510-523, 2020202
8
2020
Development of a 3‐Day Intervention Program for Family Members of Hikikomori Sufferers1
H Kubo, H Urata, M Sakai, S Nonaka, J Kishimoto, K Saito, M Tateno, ...Japanese Psychological Research 5 (2), 190-199, 2023202
6
2023
High incidence of C797S mutation in patients with long treatment history of EGFR tyrosine kinase inhibitors including osimertinib
A Osoegawa, M Yamaguchi, T Nakamura, R Morinaga, K Tanaka, ...JTO Clinical and Research Reports 2 (7), 100191, 2021202
6
2021
Effects of intensive exercise combined with dapagliflozin on body composition in patients with type 2 diabetes: a randomized controlled trial
R Bouchi, N Sonoda, J Itoh, Y Ono, T Fukuda, T Takeuchi, J Kishimoto, ...Endocrine journal 68 (3), 329-343, 2021202
5
2021
Phase 3 trial comparing nab-paclitaxel with docetaxel for previously treated advanced non-small cell lung cancer
Y Yoneshima, S Morita, M Ando, A Nakamura, S Iwasawa, H YoshiokaJ Thorac Oncol 16 (9), 1523-1532, 2021202
4
2021
Clinical trial of a cancer vaccine targeting VEGF and KIF20A in advanced biliary tract cancer
M Murahashi, T Tsuruta, K Yamada, Y Hijikata, H Ogata, J Kishimoto, ...Anticancer research 1 (3), 185-196, 2021202
4
2021
Efficacy of intensive lipid-lowering therapy with statins stratified by blood pressure levels in patients with type 2 diabetes mellitus and retinopathy: Insight from the …
K Shinohara, S Ikeda, N Enzan, S Matsushima, T Tohyama, K Funakoshi, ...Hypertension Research 44 (12), 1606-1616, 2021202
3
2021
Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial
Y Nakano, M Yamamoto, T Matoba, S Katsuki, S Nakashiro, S Takase, ...Journal of atherosclerosis and thrombosis, 63507, 0
2
2022
Serial measurement of B-type natriuretic peptide and future cardiovascular events in patients with type 2 diabetes mellitus without known cardiovascular disease
Serial measurement of B-type natriuretic peptide and future cardiovascular events in patients with type diabetes mellitus without known cardiovascular diseaseS Ikeda, K Shinohara, N Enzan, S Matsushima, T Tohyama, K Funakoshi, ...International Journal of Cardiology 356, 98-104, 0
2
2022
A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study
Y Chihara, T Takeda, Y Goto, Y Nakamura, Y Tsuchiya-Kawano, A Nakao, ...The Oncologist 7 (11), 903-e834, 0
2
2022
A higher resting heart rate is associated with cardiovascular event risk in patients with type 2 diabetes mellitus without known cardiovascular disease
A higher resting heart rate is associated with cardiovascular event risk in patients with type diabetes mellitus without known cardiovascular diseaseS Ikeda, K Shinohara, N Enzan, S Matsushima, T Tohyama, K Funakoshi, ...Hypertension Research 46 (5), 1090-1099, 030
2
2023

Referred From: https://scholar.google.com/citations?user=RGpGPA0AAAAJ&hl=en

Cited by
Citations 6104
h-index 39
i10-index 96
Recommended Journals
Open Access Journals